Page last updated: 2024-10-31

mianserin and Carcinoma, Hepatocellular

mianserin has been researched along with Carcinoma, Hepatocellular in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, YH1
Yeh, CT1

Other Studies

1 other study available for mianserin and Carcinoma, Hepatocellular

ArticleYear
Anticancer Effects of Antidepressants in Hepatocellular Carcinoma Cells.
    Anticancer research, 2023, Volume: 43, Issue:3

    Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Carcinoma, Hepatocellular; Humans;

2023